Enliven Therapeutics, Inc. (ELVN) Institutional Ownership

Institutions by Trading Activity

62,962,500Shares Outstanding

0Shares held by institutions

$0Value of institutional holdings

0.02%Institutional ownership %

-36.96%Shares Changed QoQ

4No. of institutional investors

Recent 13F filings as of December 2025 show that 4 institutional investors hold a position in Enliven Therapeutics, Inc. (NASDAQ:ELVN).

Enliven Therapeutics saw its institutional ownership percentage fell to 0.0% in December 2025 from 93.7% in September 2025.
The company experienced a -36.96% quarterly change in institutional shares held, alongside a decrease of 96.52% in total owners annually.
Among the 4 institutional holders of Enliven Therapeutics, 1 added to their stakes while 3 trimmed their positions and 0 held steady.
This class of investors decreased its holdings in Enliven Therapeutics to 14.54K shares for the 13F-cycle ending December 2025, down by 8.52K shares quarter on quarter, and down 49.60Mn shares year over year.
The top institutional stake in Enliven Therapeutics as of December 31, 2025 belongs to SG Americas Securities, LLC, which owns 14.04K shares, or 0.02% of the company.
Among the most significant buyers of Enliven Therapeutics during December 2025 were MassMutual Private Wealth & Trust, FSB (30).
Leading sellers of Enliven Therapeutics stock in December 2025 included SG Americas Securities, LLC (8.21K), Versant Capital Management, Inc (333), GAMMA Investing LLC (12).
The top 4 institutional holders of Enliven Therapeutics for the quarter ending December 2025 included SG Americas Securities, LLC (14.04K), Versant Capital Management, Inc (212), GAMMA Investing LLC (190), MassMutual Private Wealth & Trust, FSB (100).

0 Total Shares Held

Rows:

Owner Name	Date	Shares Held	Change (QoQ)	Change (%)	Value (USD)
ORBIMED ADVISORS LLC	30 Sep, 2025	7,959,538	0	0.00%	$162,931,743.00
FMR LLC	30 Sep, 2025	7,129,196	-430,705	-5.70%	$145,934,642.00
Commodore Capital LP	30 Sep, 2025	4,692,809	0	0.00%	$96,061,800.00
Fairmount Funds Management LLC	30 Sep, 2025	3,711,444	0	0.00%	$75,973,259.00
BlackRock, Inc.	30 Sep, 2025	3,518,524	551,390	18.58%	$72,024,186.00
VR Adviser, LLC	30 Sep, 2025	3,226,331	-800,000	-19.87%	$66,042,996.00
Polar Capital Holdings Plc	30 Sep, 2025	3,095,007	44,713	1.47%	$63,354,793.00
VANGUARD GROUP INC	30 Sep, 2025	2,553,014	142,378	5.91%	$52,260,198.00
JANUS HENDERSON GROUP PLC	30 Sep, 2025	1,793,583	77,171	4.50%	$36,696,708.00
Novo Holdings A/S	30 Sep, 2025	1,426,260	341,828	31.52%	$29,195,542.00
Pictet Asset Management Holding SA	30 Sep, 2025	1,398,087	430,585	44.50%	$28,618,841.00
Blackstone Inc.	30 Sep, 2025	1,320,592	0	0.00%	$27,032,518.00
Capital Research Global Investors	30 Sep, 2025	1,315,465	0	0.00%	$26,927,569.00
CITADEL ADVISORS LLC	30 Sep, 2025	1,160,503	1,160,503	0.00%	$23,755,496.00
Vestal Point Capital, LP	30 Sep, 2025	1,160,000	910,000	364.00%	$23,745,200.00
GEODE CAPITAL MANAGEMENT, LLC	30 Sep, 2025	1,085,013	202,260	22.91%	$22,213,256.00
Point72 Asset Management, L.P.	30 Sep, 2025	1,040,410	-312,668	-23.11%	$21,297,200.00
STATE STREET CORP	30 Sep, 2025	965,137	148,895	18.24%	$19,756,354.00
Duquesne Family Office LLC	30 Sep, 2025	947,405	484,405	104.62%	$19,393.00
First Turn Management, LLC	30 Sep, 2025	783,411	273,424	53.61%	$16,036,423.00

1 - 20 of 134